A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE)

Autoimmunity

Volumn 23, Issue 3, 1996, Pages 199-209

  Linker Israeli, Mariana ^a   Wallace, D J ^a   Prehn, J L ^a   Nand, R ^a   Li, L ^a   Klinenberg, J R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 6; MESSENGER RNA;

ARTICLE; DNA FLANKING REGION; GENETIC VARIABILITY; PATHOGENESIS; PEMPHIGOID; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029841573     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939608995343     Document Type: Article

References (41)

1. Cairns, E. J., St. Germain, J., Bell, D. The in vitro production of anti-DNA antibody by cultured peripheral blood or tonsillar lymphoid cells from normal donors and SLE patients. J. Immunology 1985: 135: 3839-3844.
2. Janel, R. C., George, J. L., Silberstein, D. S., Eaton, R. B., Schur, P. H. The effect of adherent cell-derived factors on immunoglobulin and anti-DNA synthesis in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1987: 42: 344-349.
3. Linker-Israeli, M., Quismorio, Jr. F. P., Horwitz, D. A. CD8+ lymphocytes from patients with SLE sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support auto-antibody synthesis. Arthritis Rheum. 1990: 33: 1216-1215.
4. Kitani, A., Hara, M., Hirose, T., Harigai, M., Suzuki, K., Kawakami, M., et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with SLE: analysis of IL-6 production and IL-6R expression. Clin. Exp. Immunol. 1992: 88: 75-83.
5. Hirano, T., Akira, S., Taga, T., Kishimoto, T. Biological and clinical aspects of Interleukin-6. Immunology Today. 1990: 11: 199-206.
6. Van Snick, J. Interleukin-6: an overview. Annu. Rev. Immunol. 1990: 11: 199-204.
7. Yasukawa, K., Hirano, T., Watanabe, T., Murashima, M., Matsuda, S., Nakai, et al. Structure and expression of human BSF-2/IL-6 gene. The EMBO J. 1987: 6: 2939-2944.
8. Horii, Y., Muraguchi, A., Iwano, M., Matsuda, T., Hirayama, T., Yamada, H., et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J. Immunol. 1989: 143: 3949-3955.
9. Grossman, R. M., Kreuger, J., Yourish, D., GranelliPiperno, A., Murphy, P. D., May, L. T., et al. IL-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA. 1989: 86: 6367-6371.
10. Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A., Lotz, M. Synovium as a source of Interleukin-6 in vitro: contribution to local and systemic manifestations of arthritis. J. Clin. Invest. 1989: 83: 585-592.
11. Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989: 74: 1360.
12. Breen, E., Rezai, A. R., Nakajima, K., Beall, G. N., Mitsuyasu, R. T., Hiro, T., et al. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 1990: 144: 480-484.
13. Deviere, J., Content, J., Denys, C., Vanderbussche, P., Schandene, L., Wybren, J. High IL-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis: correlation with IgA serum levels and lymphokine production. Clin. Exp. Immunol. 1989: 77: 221-227.
14. Hirano, T., Taga, T., Yasukawa, K., Nakajima, K., Nakano, N., Takatsuki, F., et al. Human B cell differentiation factor defined by an antipeptide antibody and its possible role in autoantibody production. Proc. Natl. Acad Sci. 1987: 84: 228-231.
15. Linker-Israeli, M., Deans, R. J. Dysregulated lymphokine production in SLE. Ann. NY Acad. Sci. 1988: 557: 567-573.
16. Linker-Israeli, M., Deans, R. J., Wallace, D. J., Prehn, J., Ozeri Chen, T., Klinenberg, J. Elevated levels of endogenous IL-6: a putative role in pathogenesis. J. Immunol. 1991: 147: 117-123.
17. Teppo, A. M., Metsarime, K., Fythrquist, F. Radioimmunoassay of IL-6 in plasma. Clin. Chem. 1991: 37: 1691-1695.
18. Pelton, B. K., Hylton, W., Denman, A. M. Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with SLE. Clin. Exp. Immunol. 1992: 89: 251-254.
19. 1 mice. J. Clin. Invest. 1994: 94: 585-591.
20. Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., McShane, D. J., Rothfield, N. F., et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum. 1982: 25: 1271-1276.
21. Liang, M. H., Socher, S. A., Larson, M. G., Schur, P. H. Reliability and validity of six systems for the clinical assessment of disease activity in SLE. Arthritis Rheum. 1989: 32: 1107-1118.
22. Sambrook, J. E., Fritsch, F., Maniatis, T. Molecular Cloning: A laboratory manual. 1989. Ch 7, 7-13.
23. Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, T., Matsuda, S., et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986: 324: 73-76.
24. Auron, P. E., Webb, C., Rosenwasser, L. J., Mucci, S. F., Rich, A., et al. Nucleotide sequence of human monocyte IL-I precursor cDNA. Proc. Natl. Acad. Sci. 1984: 81: 7907-7911.
25. Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., Kedesz, L. Isolation and characterization of full length cDNA clones for human alpha-beta-gamma actin mRNAs: skeletal but not cytoplasmic actins have an amino terminal cysteine that is subsequently removed. Mol. Cell. Biol. 1983: 3: 787-795.
26. Feinberg, A. P. Vogelstein, B. A technique for labelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 1983: 132: 6-10.
27. Bowcock, A. M., Ray, A., Erlich, H., Sehgal, P. B. Rapid detection and sequencing of alleles in the 3′ flanking region of the IL-6 gene. Nucleic Acids Research. 1989: 17: 6855-6864.
28. 2/Hepatocyte Stimulating Factor/IL-6" gene: DNA Polymorphism studies and localization to chromosome 7p21. Genomics. 1988: 3: 8-16.
29. Boulikas, T. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell. Biochem. 1993: 52: 14-22.
30. Arnett, F. C. The genetic basis of lupus erythematosus. In: Wallace, D. J., Hahn, B. H., ed. Dubois' Lupus Erythematosus, 4th ed. Lea & Febiger. 1993; 13-36.
31. Block, S. R., Winfield, J. B., Lockshin, M. D., D'Angel, W. A., Christian, L. C. Studies with twins with SLE. A review of the literature and presentation of 12 additional cases. Amer. J. Med. 1975: 59: 532-552.
32. Wilson, D. W., Scopetelis, E., Michalski, J. P. Association of susceptibility to SLE in Caucasian and Black Americans. J. Rheum. 1986: 11: 653-657.
33. Fronek, Z., Timmerman, L. A., Alper, C.A., Hahn, B. H., Kalunian, K., Peterlin, M. B., et al. MHC complex genes and susceptibility to SLE. Arthritis Rheum. 1990: 33: 1542-1553.
34. Winchester, R. J. Genetic aspects in the clinical management of SLE. Ed. PH Schur, Grune and Stratton 1983: 17-29.
35. Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., McDevitt, H. O. Heritable major histocompatibility complex class-II associated differences in production of tumor necrosis factor-alpha; relevance to genetic predisposition to SLE. Proc. Natl. Acad. Sci. USA. 1990: 87: 1233-1237.
36. Frank, M. B., McArthur, R., Harley, J. B., Fujisaku, A. Anti Ro (SSA) autoantibodies are associated with T-cell receptor beta genes in SLE patients. J. Clin. Invest. 1990: 85: 33-39.
37. Tebib, J. G., Alcocer-Varela, J., Alarcon-Segovia, D., Schur, P. Association between a T cell receptor restriction fragment length polymorphism and SLE. J. Clin. Invest. 1990: 86: 1961-1967.
38. Clark, M., Liu, L., Clarkson, S. B., Ory, P. A., Goldstein, I. M. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with SLE. J. Clin. Invest. 1990: 86: 341-346.
39. Tomita, Y., Hashimoto, S., Yamagami, K., Sawada, S., Horie, T. RFLP analysis in the TNF genes of patients with SLE. Clin. Exp. Rheum. 1992: 11(5): 533-536.
40. Fugger, L., Morling, N., Sandberg-Wollheim, M., Ryder, L. P., Svejgaard, A. TNF-alpha gene polymorphism in MS and optic neuritis. J. Neuroimmunol. 1990: 27(1): 85-88.
41. Bailly S., di Giovinne, F. S., Blakemore, A. I., Duff, G. W. Genetic polymorphism of human IL-1 alpha. Eur. J. Immunol. 1993: 23(6): 1240-1245.